Abstract
Background: Annona muricata L. (Annonaceae) (AM)'s remarkable anti-inflammatory and anti-cancer activities make it a targeted plant to be explored for its immunomodulatory properties. Traditional practitioners have employed various components of AM to cure a variety of ailments, including cancer, diabetes, and inflammation.
Objective: The present study evaluated the immunosuppressive effects of 80% ethanol extract of of AM leaves in male Wistar rats on different parameters of humoral and cellular immune responses.
Methods: AM leaf extract (AMLE) was analyzed using UHPLC-MS/MS to profile its secondary metabolites. AMLE was rich in polyphenols which include (epi)catechin-(epi)catechin-(epi) catechin, caffeic acid, coumaroylquinic acid, hyperin, kaempferol, quinic acid and rutin. The rats were administered 100, 200 and 400 mg/kg bw of the extract daily for 14 days. The effects of AMLE on innate immune responses were determined by evaluating phagocytosis, neutrophils migration, reactive oxygen species (ROS) release, CD11b/CD18 integrin expression, and ceruloplasmin, lysozyme and myeloperoxidase (MPO) levels. The adaptive immune parameters were evaluated by immunizing the rats with sheep red blood cells (sRBC) on day 0 and administered orally with AMLE for 14 days.
Results: AMLE established significant immunosuppressive effects on the innate immune parameters by inhibiting the neutrophil migration, ROS production, phagocytic activity and expression of CD11b/CD18 integrin in a dose-dependent pattern. AMLE also suppressed ceruloplasmin, MPO and lysozyme expressions in the rat plasma dose-dependently. AMLE dose-dependently inhibited T and B lymphocytes proliferation, Th1 and Th2 cytokine production, CD4+ and CD8+ co-expression in splenocytes, immunoglobulins (IgM and IgG) expression and the sRBC-induced swelling rate of rat paw in delayed-type hypersensitivity (DTH).
Conclusion: The strong inhibitory effects on the different parameters of humoral and cellular responses indicate that AMLE has potential to be an important source of effective immunosuppressive agents.
Graphical Abstract
[http://dx.doi.org/10.1016/j.jaci.2009.09.017] [PMID: 20061006]
[http://dx.doi.org/10.1007/s00044-018-2163-3]
[http://dx.doi.org/10.4161/mabs.1.6.9884] [PMID: 20073129]
[http://dx.doi.org/10.1155/2015/401630] [PMID: 25961060]
[http://dx.doi.org/10.1002/ptr.5633] [PMID: 27137750]
[http://dx.doi.org/10.3389/fphar.2018.00661] [PMID: 29973884]
[http://dx.doi.org/10.18311/jnr/2016/5367]
[http://dx.doi.org/10.1016/j.ijsu.2015.03.026] [PMID: 25899210]
[http://dx.doi.org/10.4314/ajtcam.v12i4.3]
[http://dx.doi.org/10.1016/j.jep.2016.05.045] [PMID: 27224241]
[http://dx.doi.org/10.1016/j.biopha.2017.07.133] [PMID: 28779710]
[http://dx.doi.org/10.1016/j.intimp.2011.04.011] [PMID: 21530682]
[PMID: 26089645]
[http://dx.doi.org/10.1177/1087057106299162] [PMID: 17438069]
[http://dx.doi.org/10.1172/JCI0215093] [PMID: 11854312]
[http://dx.doi.org/10.4103/0974-8490.81961] [PMID: 21772757]
[http://dx.doi.org/10.1002/ibd.20348] [PMID: 18200517]
[http://dx.doi.org/10.1016/S1074-7613(00)80278-2] [PMID: 8986723]
[http://dx.doi.org/10.1083/jcb.144.5.1047] [PMID: 10085300]
[http://dx.doi.org/10.1046/j.1365-2036.2000.014s1074.x]
[http://dx.doi.org/10.1038/nri2156] [PMID: 17717539]
[http://dx.doi.org/10.1128/IAI.68.2.449-455.2000] [PMID: 10639403]
[http://dx.doi.org/10.2174/18735592MTAwhMzkdy] [PMID: 31433756]
[http://dx.doi.org/10.1016/j.talanta.2008.11.002] [PMID: 19174227]
[http://dx.doi.org/10.1172/JCI11914] [PMID: 11160126]
[http://dx.doi.org/10.1046/j.1440-1711.2000.00884.x] [PMID: 10651929]
[http://dx.doi.org/10.1016/j.bcp.2004.03.015] [PMID: 15183117]
[http://dx.doi.org/10.1038/sj.bjp.0702803] [PMID: 10510448]
[http://dx.doi.org/10.1371/journal.pone.0067746] [PMID: 23840769]
[PMID: 77879]
[PMID: 7044959]
[http://dx.doi.org/10.4049/jimmunol.174.5.2619] [PMID: 15728468]